Q1 Earnings Snapshot 2026 – Winners, Surprises & Misses Revealed!

LARSEN & TOUBRO (L&T) – Q1FY27 RESULTS

CMP: — | M.Cap: — | P/E: —

Ambuja Cements Ltd. – Q1FY27 Results

Price: ₹598 | M.Cap: ₹1,47,000 Cr | P/E: 38.5

Verdict

Ambuja Cements reported a mixed Q1FY27 performance. Revenue declined ▼ 7.7% YoY and missed market expectations due to weaker realizations and demand. However, the company delivered a stronger-than-expected operating performance, with EBITDA, EBITDA margin, and net profit comfortably beating CNBC-TV18 estimates. Despite lower year-on-year profitability, the earnings beat indicates better cost control and operational efficiency.

Supreme Industries Ltd. – Q1FY27 Results

Price: — | M.Cap: — | P/E: —

Varun Beverages Ltd. (Q2CY26 Results)

Supreme Industries Ltd. – Q1FY27 Results

Price: ₹3,395 | M.Cap: ₹43,142 Cr | P/E: 41.8

Verdict

Supreme Industries delivered a strong year-on-year performance in Q1FY27, supported by healthy margin expansion and robust growth in profitability. Sales increased 4% YoY, while EBITDA and net profit surged 25% and 39%, respectively, reflecting improved operating efficiency. On a sequential basis, revenue and earnings declined from the seasonally stronger March quarter, leading to lower QoQ comparisons. Overall, the results remain positive, highlighting the company’s resilient profitability despite seasonal moderation in demand.

Paradeep Phosphates Ltd. – Q1FY27 Results

Price: ₹139 | M.Cap: ₹14,489 Cr | P/E: 13.3

Verdict

Paradeep Phosphates Ltd. delivered a strong Q1FY27 performance with healthy growth in revenue, EBITDA, and net profit on both a year-on-year and quarter-on-quarter basis. Revenue growth was supported by improved business momentum, while operating profitability expanded significantly, resulting in a sharp rise in quarterly earnings. Although EPS declined marginally by 3% YoY, it surged 152% sequentially, reflecting a strong recovery in profitability. Overall, the quarterly performance remains positive and indicates continued operational strength.

VST Industries – Q1FY27 Results

Price: ₹229 | Market Cap: ₹3,896 Cr | P/E: 14.0

Verdict

VST Industries reported a weak Q1FY27 performance, with revenue, EBITDA, net profit, and EPS declining on both a YoY and QoQ basis. The sharp drop in operating profitability indicates pressure on business performance during the quarter, reflecting a subdued earnings trend.

Birlasoft Ltd – Q1FY27 Results

Price: ₹300 | M.Cap: ₹8,382 Cr | P/E: 14.1

Verdict

Birlasoft delivered a strong Q1FY27 performance on a year-on-year basis, driven by healthy revenue growth, significant margin expansion, and robust profit growth. However, on a sequential basis, profitability moderated with declines in EBITDA, net profit, and EPS despite steady revenue growth, indicating some margin pressure during the quarter.

Netweb Technologies – Q1FY27 Results

Price: ₹4,396 | M.Cap: ₹25,020 Cr | P/E: 96.0

Verdict

Netweb Technologies delivered an outstanding Q1FY27 performance, reporting exceptional triple-digit year-on-year growth across revenue, EBITDA, net profit, and EPS. Sequential growth also remained healthy, reflecting sustained demand, strong execution, and continued operational momentum. Overall, the results are highly positive and reinforce the company’s strong growth trajectory.

Tata Capital – Q1FY27 Results

Price: ₹355 | M.Cap: ₹1,50,607 Cr | P/E: 27.7

Verdict

Tata Capital delivered a strong Q1FY27 performance with healthy growth across all key financial metrics. Revenue increased steadily, while EBITDA and net profit grew at a faster pace, indicating improved operational efficiency and profitability. The sharp rise in earnings reflects robust business momentum and effective cost management, positioning the company well for sustained growth.

Century Enka – Q1FY27 Results

Price: ₹600 | M.Cap: ₹1,311 Cr | P/E: 8.8

Verdict

Century Enka reported a strong Q1FY27 performance with robust growth across revenue, EBITDA, net profit, and EPS. Significant margin expansion and sharp earnings growth reflect improved operational efficiency and healthy business momentum, indicating a solid start to the financial year.

Pfizer – Q1FY27 Results

Price: ₹4,711 | M.Cap: ₹21,562 Cr | P/E: 28.0

Verdict

Pfizer reported a healthy Q1FY27 performance with steady revenue growth and improved profitability. EBITDA growth outpaced sales, reflecting better operational efficiency and margin expansion. Net profit and EPS also registered consistent growth on both YoY and QoQ basis, indicating stable business momentum and continued earnings resilience.

Cemindia Project – Q1FY27 Results

Price: ₹1,341 | M.Cap: ₹23,032 Cr | P/E: 38.3

Verdict

Revenue and EBITDA delivered healthy year-on-year growth, reflecting steady business momentum. However, net profit remained largely flat despite higher operating earnings. On a sequential basis, performance weakened significantly, with EBITDA and net profit declining sharply, indicating margin pressure and lower profitability during the quarter.

Radico Khaitan – Q1FY27 Results

Price: ₹4,290 | M.Cap: ₹57,483 Cr | P/E: 80.9

Note: Exceptional item of ₹6.99 Cr in Jun 2025 has been ignored for YoY comparison.

Verdict

Pine Labs – Q1FY27 Results

Price: ₹153 | M.Cap: ₹17,646 Cr | P/E: 136.4

Verdict

Suzlon Energy – Q1FY27 Results

Price: ₹48.0 | M.Cap: ₹65,468 Cr | P/E: 20.8

Verdict

Suzlon Energy reported healthy revenue growth with sales rising ▲ 22% YoY, reflecting strong business momentum. However, profitability weakened as EBITDA declined ▼ 1% YoY, while net profit and EPS fell ▼ 6% and ▼ 8% respectively. On a sequential basis, earnings were significantly lower due to margin pressure and a softer quarterly performance.

Deep Industries – Q1FY27 Results

Price: ₹507 | M.Cap: ₹3,243 Cr | P/E: 7.8

Verdict

TTK Prestige – Q1FY27 Results

Price: ₹702 | M.Cap: ₹9,586 Cr | P/E: 46.3

Verdict

TTK Prestige reported an excellent Q1FY27 performance with strong double-digit revenue growth and a sharp improvement in profitability. EBITDA and net profit more than doubled on a year-on-year basis, supported by healthy margin expansion and improved operating leverage. The strong sequential growth across all key financial metrics indicates sustained business momentum and improving demand outlook.

Varun Beverages – Q1FY27 Results

Price: ₹430 | Market Cap: ₹1,45,462 Cr | P/E: 43.0

Verdict

Varun Beverages delivered a strong Q1FY27 performance with healthy double-digit year-on-year growth across revenue, EBITDA, net profit and EPS. Sequentially, the company posted a sharp improvement supported by robust seasonal demand, higher beverage volumes and operating leverage, reflecting strong execution during the peak summer season.

Indoco Remedies – Q1FY27 Results

Price: ₹228 | Market Cap: ₹2,108 Cr

Verdict

Indoco Remedies delivered a strong turnaround in Q1FY27, driven by a sharp improvement in profitability. Revenue growth remained modest at 6% YoY, but EBITDA more than doubled, supported by a significant expansion in operating margins. The company reported a healthy net profit against losses in both the previous quarter and the year-ago period. While EBITDA moderated sequentially, the return to profitability and improved margins indicate strengthening operational performance.

Indus Towers – Q1FY27 Results

Price: ₹382 | M.Cap: ₹1,00,855 Cr | P/E: 14.1

Verdict

Indus Towers reported a stable Q1FY27 with modest revenue growth. Sales and EBITDA improved on both a YoY and QoQ basis, reflecting steady operating performance. However, net profit and EPS remained largely flat YoY and declined marginally sequentially. Overall, the company delivered a consistent quarter with stable fundamentals.